Geneva Partners, LLC’s Eli Lilly & Co Position
Does Geneva Partners, LLC own Eli Lilly & Co (LLY)? Yes — 5.1K shares worth $5M (+2.26% of its 13F portfolio) as of Q1 2026, down from 15.7K shares the prior filed quarter.
Position Value
$5M
Q1 2026
Shares
5.1K
% of Portfolio
+2.26%
Quarters Held
19
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 5.1K | $5M | +2.26% |
| Q4 2025 | 15.7K | $17M | +6.01% |
| Q3 2025 | 2.7K | $2M | +0.76% |
| Q2 2025 | 4.6K | $4M | +1.43% |
| Q1 2025 | 4.6K | $4M | +1.95% |
| Q4 2024 | 8.5K | $7M | +2.68% |
| Q3 2024 | 8.7K | $8M | +3.35% |
| Q2 2024 | 9.3K | $8M | +3.46% |
| Q1 2024 | 8.3K | $6M | +2.83% |
| Q4 2023 | 8.7K | $5M | +2.80% |
| Q3 2023 | 9.1K | $5M | +3.24% |
| Q2 2023 | 5.2K | $2M | +1.60% |
| Q1 2023 | 3.6K | $1M | +1.06% |
| Q4 2022 | 4.1K | $1M | +1.41% |
| Q1 2022 | 3.1K | $875,000 | +0.54% |
| Q4 2021 | 1.5K | $414,000 | +0.20% |
| Q3 2020 | 30.1K | $4M | +2.72% |
| Q2 2020 | 30.5K | $5M | +3.51% |
| Q1 2020 | 25.0K | $3M | +4.94% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Geneva Partners, LLC’s full portfolio or all institutional holders of LLY.